PhageAC

PhageAC is a topical targeted essence gel developed by Hong Kong Rising Biotechnology for the treatment of acne. It utilizes a phage-based approach, presumably employing bacteriophages to specifically target and eliminate *Cutibacterium acnes* (formerly *Propionibacterium acnes*), the primary bacteria associated with acne vulgaris, while maintaining the skin's natural microbiome. By selectively lysing pathogenic bacteria without the use of broad-spectrum antibiotics, PhageAC aims to reduce inflammation and clear acne lesions with a high degree of specificity. As of the current pipeline information, it is positioned as a targeted skincare or therapeutic product, though specific clinical phases or detailed genomic information regarding the phage strains have not been publicly disclosed.

Brand names

PhageAC